Search
Displaying results 61 to 70 of 107.
Who benefits from immunotherapy against hepatitis B?
It is estimated that more than 250 million people worldwide are chronically infected with the hepatitis B virus. Cytotoxic T cells and T helper cells play an important role in fighting viral infections. The constant activation of these immune cells in chronically…
The path to personalised hepatitis D treatment
Hepatitis D is caused by coinfection of hepatitis B patients with the hepatitis D virus (HDV). Up to 20 Million individuals are infected with HDV worldwide including about 250.000 patients in the European Union. There is very limited knowledge on disease pathophysiology…
When the skin aches
It was already known that in both psoriasis and neurodermatitis, T-cells of the immune system migrate from the blood into the skin and drive the inflammation there. Detailed examination of T-cells in blood and skin now led to evidence that in atopic dermatitis they…
COVID-19 Patientenkohorte hilft bei Aufklärung des Patientenrisikos
Aus der MHH stammen Bioproben und Daten der „ COVID-19-Kohorte “, die seit März 2020 von unterschiedlich stark am Coronavirus SARS-CoV-2 erkrankten Patientinnen und Patienten sowie Kontrollproben von Menschen mit anderen Atemwegserkrankungen aus verschiedenen…
Joint symposium of HZI and McGill University on personalised infection medicine
Personalised infection medicine aims to take into account individual differences in the diagnosis and therapy of infectious diseases. The HZI and McGill University have been building a strategic cooperation on this topic for several years. Clinicians and scientists from…